WO2002057415A3 - Method for altering cell fate - Google Patents
Method for altering cell fate Download PDFInfo
- Publication number
- WO2002057415A3 WO2002057415A3 PCT/US2001/047882 US0147882W WO02057415A3 WO 2002057415 A3 WO2002057415 A3 WO 2002057415A3 US 0147882 W US0147882 W US 0147882W WO 02057415 A3 WO02057415 A3 WO 02057415A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell fate
- altering cell
- cell
- cell type
- altering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01993249A EP1356277B1 (en) | 2000-12-22 | 2001-12-11 | Method for altering cell fate |
JP2002558469A JP4332348B2 (en) | 2000-12-22 | 2001-12-11 | How to change cell fate |
AT01993249T ATE555380T1 (en) | 2000-12-22 | 2001-12-11 | METHOD FOR ALTERING THE FATE OF CELLS |
AU2002245101A AU2002245101B2 (en) | 2000-12-22 | 2001-12-11 | Method for altering cell fate |
CA2429954A CA2429954C (en) | 2000-12-22 | 2001-12-11 | Method for altering cell fate |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25815200P | 2000-12-22 | 2000-12-22 | |
US60/258,152 | 2000-12-22 | ||
US10/015,824 | 2001-12-10 | ||
US10/015,824 US20020142397A1 (en) | 2000-12-22 | 2001-12-10 | Methods for altering cell fate |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002057415A2 WO2002057415A2 (en) | 2002-07-25 |
WO2002057415A3 true WO2002057415A3 (en) | 2002-12-27 |
Family
ID=26687840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/047882 WO2002057415A2 (en) | 2000-12-22 | 2001-12-11 | Method for altering cell fate |
Country Status (7)
Country | Link |
---|---|
US (2) | US20020142397A1 (en) |
EP (1) | EP1356277B1 (en) |
JP (2) | JP4332348B2 (en) |
AT (1) | ATE555380T1 (en) |
AU (1) | AU2002245101B2 (en) |
CA (1) | CA2429954C (en) |
WO (1) | WO2002057415A2 (en) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7621606B2 (en) * | 2001-08-27 | 2009-11-24 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
US20110171185A1 (en) * | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
US20020142397A1 (en) * | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
US7491534B2 (en) * | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
EP1356035B1 (en) * | 2000-12-22 | 2011-03-16 | Kyowa Hakko Kirin Co., Ltd. | Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells |
WO2003018780A1 (en) * | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
AU2003287444A1 (en) * | 2002-10-31 | 2004-05-25 | The General Hospital Corporation | Repairing or replacing tissues or organs |
AU2002952944A0 (en) * | 2002-11-27 | 2002-12-12 | Human Genetic Signatures Pty Ltd | Restoration of methylation states in cells |
AU2003900368A0 (en) * | 2003-01-24 | 2003-02-13 | Human Genetic Signatures Pty Ltd | Assay for nucleic acid molecules |
AU2004232917A1 (en) * | 2003-04-21 | 2004-11-04 | University Of Massachusetts | Reprogramming nuclear function with somatic cell cytoplasm |
US7288373B2 (en) * | 2003-05-02 | 2007-10-30 | Human Genetic Signatures Pty Ltd. | Treatment of methylated nucleic acid |
US7799525B2 (en) * | 2003-06-17 | 2010-09-21 | Human Genetic Signatures Pty Ltd. | Methods for genome amplification |
WO2005024053A1 (en) | 2003-09-04 | 2005-03-17 | Human Genetic Signatures Pty Ltd | Nucleic acid detection assay |
WO2005033297A1 (en) * | 2003-09-19 | 2005-04-14 | The Rockefeller University | Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
US7135336B1 (en) | 2004-04-21 | 2006-11-14 | University Of South Florida | Use of Xenopus laevis oocytes a microincubators |
US8168777B2 (en) | 2004-04-29 | 2012-05-01 | Human Genetic Signatures Pty. Ltd. | Bisulphite reagent treatment of nucleic acid |
WO2006026828A1 (en) * | 2004-09-10 | 2006-03-16 | Human Genetic Signatures Pty Ltd | Amplification blocker comprising intercalating nucleic acids (tna) containing intercalating pseudonucleotides (ipn) |
NZ555620A (en) * | 2004-12-03 | 2008-08-29 | Human Genetic Signatures Pty | Methods for simplifying microbial nucleic acids by chemical modification of cytosines |
US20090029346A1 (en) * | 2004-12-23 | 2009-01-29 | Human Genetic Signatures Pty., Ltd. | Detection of human papilloma virus |
US20060182724A1 (en) * | 2005-02-15 | 2006-08-17 | Riordan Neil H | Method for expansion of stem cells |
FR2885368A1 (en) * | 2005-05-04 | 2006-11-10 | Fred Zacouto | Treating cells genetically/epigenetically to treat diseases, involves contacting nucleus of to-be-treated cell with genetic reprogramming medium having natural cytoplasm of genetic reprogramming cell, to modify biological age |
AU2006251866B2 (en) * | 2005-05-26 | 2007-11-29 | Human Genetic Signatures Pty Ltd | Isothermal strand displacement amplification using primers containing a non-regular base |
WO2007026255A2 (en) * | 2005-06-22 | 2007-03-08 | Universitetet I Oslo | Dedifferentiated cells and methods of making and using dedifferentiated cells |
EP1984487B1 (en) | 2005-08-03 | 2022-10-12 | Astellas Institute for Regenerative Medicine | Improved methods of reprogramming animal somatic cells |
US8343738B2 (en) * | 2005-09-14 | 2013-01-01 | Human Genetic Signatures Pty. Ltd. | Assay for screening for potential cervical cancer |
US20070087437A1 (en) * | 2005-10-14 | 2007-04-19 | Jifan Hu | Methods for rejuvenating cells in vitro and in vivo |
AU2007285483B2 (en) | 2006-05-11 | 2011-12-22 | Regenics As | Administration of cells and cellular extracts for rejuvenation |
US20080050738A1 (en) * | 2006-05-31 | 2008-02-28 | Human Genetic Signatures Pty Ltd. | Detection of target nucleic acid |
US20100135970A1 (en) * | 2006-10-27 | 2010-06-03 | Caritas St. Elizabeth Medical Center Of Boston, In | Methods for Reprogramming Adult Somatic Cells and Uses Thereof |
WO2008113111A1 (en) * | 2007-03-16 | 2008-09-25 | Human Genetic Signatures Pty Ltd | Assay for gene expression |
JP2008307007A (en) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth |
WO2009062157A1 (en) * | 2007-11-09 | 2009-05-14 | Michigan State University | Epigenetic modification of cell phenotype, fate and/or function by rna transfer |
EP2215250B1 (en) * | 2007-11-27 | 2013-02-27 | Human Genetic Signatures Pty Ltd | Enzymes for amplification and copying bisulphite modified nucleic acids |
US20110003700A1 (en) * | 2007-12-20 | 2011-01-06 | Human Genetic Signatures Pty Ltd. | Elimination of contaminants associated with nucleic acid amplification |
WO2009098698A2 (en) | 2008-02-07 | 2009-08-13 | Shahar Cohen | Compartmental extract compositions for tissue engineering |
EP2296676B1 (en) | 2008-05-09 | 2016-11-02 | Regenics AS | Cellular extracts |
WO2010056831A2 (en) * | 2008-11-12 | 2010-05-20 | Nupotential, Inc. | Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator |
US20100310527A1 (en) * | 2009-01-09 | 2010-12-09 | Board Of Regents Of The University Of Texas System | Liposome mediated delivery of lineage determining factors |
US9249412B2 (en) | 2009-01-26 | 2016-02-02 | Fred Zacouto | Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1 |
JP5777081B2 (en) | 2009-12-16 | 2015-09-09 | 国立研究開発法人理化学研究所 | Method for homoplasmicization of heteroplasmy cells |
EP2533859B1 (en) | 2010-02-10 | 2016-04-06 | Nayacure Therapeutics Ltd | Pharmaceutical compositions for the treatment and prevention of cancer |
US11225655B2 (en) | 2010-04-16 | 2022-01-18 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
AU2011249478B2 (en) | 2010-05-06 | 2014-12-04 | Regenics As | Use of cellular extracts for skin rejuvenation |
WO2012054896A1 (en) | 2010-10-22 | 2012-04-26 | Biotime Inc. | Methods of modifying transcriptional regulatory networks in stem cells |
US20120184035A1 (en) * | 2011-01-13 | 2012-07-19 | Sadhana Agarwal | Methods and Compositions For Reprogramming Cells |
AU2012225784B2 (en) | 2011-03-04 | 2016-03-17 | The Regents Of The University Of California | Locally released growth factors to mediate motor recovery after stroke |
US10865383B2 (en) | 2011-07-12 | 2020-12-15 | Lineage Cell Therapeutics, Inc. | Methods and formulations for orthopedic cell therapy |
CN103874766B (en) | 2011-09-07 | 2017-07-18 | 人类遗传标记控股有限公司 | Molecular Detection is determined |
CA2875294C (en) | 2012-04-25 | 2021-06-08 | Riken | Cell preparation containing myocardium-committed cell |
AU2013237760A1 (en) | 2012-10-08 | 2014-04-24 | Biotime, Inc. | Differentiated progeny of clonal progenitor cell lines |
EP3459522B1 (en) | 2012-12-10 | 2021-02-17 | Regenics AS | Use of egg cellular extracts for wound treatment |
US10961531B2 (en) | 2013-06-05 | 2021-03-30 | Agex Therapeutics, Inc. | Compositions and methods for induced tissue regeneration in mammalian species |
KR102105532B1 (en) * | 2013-10-17 | 2020-04-29 | (주)아모레퍼시픽 | Method for derivation of inducible Pluripotent stem cells and inducible Pluripotent stem cells produced using the same |
JP6508873B2 (en) * | 2014-01-20 | 2019-05-08 | 国立大学法人富山大学 | Method for obtaining antigen-specific T cell receptor |
US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
US20180237847A1 (en) * | 2015-08-20 | 2018-08-23 | Genomatica, Inc. | Compositions and multiplexed systems for coupled cell-free transcription-translation and protein synthesis and methods for using them |
WO2017100313A1 (en) | 2015-12-07 | 2017-06-15 | Biotime, Inc. | Methods for the re-derivation of diverse pluripotent stem cell-derive brown fat cells |
US10960071B2 (en) | 2017-08-07 | 2021-03-30 | The Regents Of The University Of California | Platform for generating safe cell therapeutics |
KR20200037353A (en) * | 2017-08-07 | 2020-04-08 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Platform for creating safe cell therapy products |
CN108103027B (en) * | 2018-02-02 | 2021-12-24 | 中国医学科学院血液病医院(血液学研究所) | Method for reprogramming blood cells with high efficiency and simultaneously realizing gene editing |
KR20220140542A (en) * | 2020-02-07 | 2022-10-18 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Methods and uses for bioengineered preparation of enucleated cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001654A (en) * | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1293460C (en) | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
US4994384A (en) | 1986-12-31 | 1991-02-19 | W. R. Grace & Co.-Conn. | Multiplying bovine embryos |
US5470560A (en) | 1987-01-20 | 1995-11-28 | Genentech, Inc. | Method for evaluating immunogenicity |
EP0832981A1 (en) | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
US5057420A (en) | 1987-06-05 | 1991-10-15 | Granada Biosciences, Inc. | Bovine nuclear transplantation |
US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
US5213979A (en) | 1987-12-30 | 1993-05-25 | W. R. Grace & Co.-Conn. | In vitro culture of bovine embryos |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
DE4000939A1 (en) | 1990-01-15 | 1991-07-18 | Brem Gottfried Prof Dr Dr | METHOD FOR OBTAINING ANTIBODIES |
US5160312A (en) | 1990-02-09 | 1992-11-03 | W. R. Grace & Co.-Conn. | Cryopreservation process for direct transfer of embryos |
US5614396A (en) | 1990-06-14 | 1997-03-25 | Baylor College Of Medicine | Methods for the genetic modification of endogenous genes in animal cells by homologous recombination |
US5453366A (en) | 1990-07-26 | 1995-09-26 | Sims; Michele M. | Method of cloning bovine embryos |
US5096822A (en) | 1990-07-26 | 1992-03-17 | W. R. Grace & Co.- Conn. | Bovine embryo medium |
US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
ES2246502T3 (en) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | TRANSGENIC NON-HUMAN ANIMALS ABLE TO PRODUCE HETEROLOGICAL ANTIBODIES. |
US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
WO1992003917A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International | Homologous recombination in mammalian cells |
US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
WO1992015694A1 (en) | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
US5240840A (en) | 1991-04-05 | 1993-08-31 | Regents Of The University Of Michigan | Dna superfragment cloning |
AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
WO1993007266A1 (en) | 1991-10-07 | 1993-04-15 | Idaho Research Foundation, Inc. | Genetic construct for selection of homologous recombinants on a single selective medium |
SG47979A1 (en) | 1991-11-14 | 1998-04-17 | Charles Weissman | Transgenic animals lacking prion proteins |
EP0626999A4 (en) | 1992-01-24 | 1997-04-09 | Life Technologies Inc | Modulation of enzyme activities in the -i(in vivo) cloning of dna. |
US5843643A (en) | 1992-02-21 | 1998-12-01 | Ratner; Paul L. | Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid |
US5763240A (en) | 1992-04-24 | 1998-06-09 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
US5654183A (en) * | 1992-07-27 | 1997-08-05 | California Institute Of Technology | Genetically engineered mammalian neural crest stem cells |
US6107543A (en) | 1992-08-20 | 2000-08-22 | Infigen, Inc. | Culture of totipotent embryonic inner cells mass cells and production of bovine animals |
US5480772A (en) | 1993-02-03 | 1996-01-02 | Brandeis University | In vitro activation of a nucleus |
US5496720A (en) | 1993-02-10 | 1996-03-05 | Susko-Parrish; Joan L. | Parthenogenic oocyte activation |
EP1621627A3 (en) | 1993-03-16 | 2006-06-07 | The Austin Research Institute | Use of porcine gala (1,3) galactosyl transferase in xenograft therapies |
DE69425903T2 (en) | 1993-12-09 | 2001-02-15 | Thomas Jefferson University Ph | CONNECTIONS AND METHOD FOR LOCATION-SPECIFIC MUTATION IN EUKARYOTIC CELLS |
US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
DE69535752D1 (en) | 1994-04-13 | 2008-06-26 | Biotransplant Inc | ALPHA (1,3) GALACTOSYL TRANSFERASE NEGATIVE PIG |
US5723331A (en) | 1994-05-05 | 1998-03-03 | Genzyme Corporation | Methods and compositions for the repair of articular cartilage defects in mammals |
US5583016A (en) | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
US5876979A (en) | 1994-07-07 | 1999-03-02 | Cold Spring Harbor Laboratory | RNA component of mouse, rat, Chinese hamster and bovine telomerase |
US5780296A (en) | 1995-01-17 | 1998-07-14 | Thomas Jefferson University | Compositions and methods to promote homologous recombination in eukaryotic cells and organisms |
US5776744A (en) | 1995-06-07 | 1998-07-07 | Yale University | Methods and compositions for effecting homologous recombination |
US5952222A (en) | 1995-08-04 | 1999-09-14 | The Board Of Trustees Of The University Of Arkansas | Functional enucleation of bovine oocytes |
US5733730A (en) | 1995-08-25 | 1998-03-31 | The Rockefeller University | Telomere repeat binding factor and diagnostic and therapeutic use thereof |
US7332648B2 (en) | 1995-08-31 | 2008-02-19 | Roslin Institute | Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates |
GB9517779D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5695977A (en) | 1995-08-31 | 1997-12-09 | Genetic Information Research Institute | Site directed recombination |
GB9517780D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5801030A (en) | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
US5679523A (en) | 1995-11-16 | 1997-10-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method for concurrent disruption of expression of multiple alleles of mammalian genes |
US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
US5905042A (en) | 1996-04-01 | 1999-05-18 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Cultured inner cell mass cell lines derived from bovine or porcine embryos |
US20060021070A1 (en) | 1996-04-01 | 2006-01-26 | University of Massachusetts, a Public Institution of Higher Education of the Commonwealth of MA | Production of chimeric bovine or porcine animals using cultured inner cell mass |
US5770422A (en) | 1996-07-08 | 1998-06-23 | The Regents Of The University Of California | Human telomerase |
US20020194637A1 (en) | 2001-06-06 | 2002-12-19 | University Of Massachussetts | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
US20010012513A1 (en) | 1996-08-19 | 2001-08-09 | University Of Massachusetts | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
US7696404B2 (en) | 1996-08-19 | 2010-04-13 | Advanced Cell Technology, Inc. | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
NZ334016A (en) | 1996-08-19 | 2000-08-25 | Univ Massachusetts | Embryonic stem cell lines produced by cross species nuclear transplantation |
JP2002511732A (en) | 1996-10-11 | 2002-04-16 | ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム | Compositions and methods for generating transgenic animals |
US20020012655A1 (en) | 1997-01-10 | 2002-01-31 | Steven L. Stice | Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease |
US20010039667A1 (en) | 1997-01-10 | 2001-11-08 | University Of Massachusetts | Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease |
US6235969B1 (en) | 1997-01-10 | 2001-05-22 | University Of Massachusetts | Cloning pigs using donor nuclei from non-quiescent differentiated cells |
US6215041B1 (en) | 1997-01-10 | 2001-04-10 | University Of Mmassachusetts | Cloning using donor nuclei from a non-quiesecent somatic cells |
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
US6011197A (en) | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
US5830698A (en) | 1997-03-14 | 1998-11-03 | Idec Pharmaceuticals Corporation | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
US6211429B1 (en) | 1997-06-18 | 2001-04-03 | The Curators Of The University Of Missouri | Complete oocyte activation using an oocyte-modifying agent and a reducing agent |
US20020019993A1 (en) | 1998-01-21 | 2002-02-14 | Teruhiko Wakayama | Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
TWI255853B (en) | 1998-08-21 | 2006-06-01 | Kirin Brewery | Method for modifying chromosomes |
US6258998B1 (en) | 1998-11-24 | 2001-07-10 | Infigen, Inc. | Method of cloning porcine animals |
US20020012660A1 (en) | 1999-03-04 | 2002-01-31 | Alan Colman | Method of preparing a somatic cells for nuclear transfer |
US20040199935A1 (en) | 1999-06-30 | 2004-10-07 | Chapman Karen B. | Cytoplasmic transfer to de-differentiate recipient cells |
JP2003503071A (en) | 1999-06-30 | 2003-01-28 | アドバンスド セル テクノロジー、インコーポレイテッド | Cytoplasmic transfer to dedifferentiated recipient cells |
US6808704B1 (en) | 1999-09-07 | 2004-10-26 | Advance Cell Technology, Inc. | Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
BR0014857A (en) | 1999-10-14 | 2003-07-08 | Univ Ofd Massachusetts Public | Nuclear transplant donor cell preparation and selection |
MXPA02003733A (en) | 1999-10-15 | 2003-10-14 | Advanced Cell Tech Inc | Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells. |
US20030129745A1 (en) | 1999-10-28 | 2003-07-10 | Robl James M. | Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
AU1581001A (en) | 1999-11-02 | 2001-05-14 | University Of Massachusetts | Use of haploid genomes for genetic diagnosis, modification and multiplication |
US7074983B2 (en) | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
US7414170B2 (en) | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
CA2394600A1 (en) | 1999-12-17 | 2001-06-21 | Oregon Health And Science University | Methods for producing transgenic animals |
WO2001049106A2 (en) | 2000-01-04 | 2001-07-12 | University Of Connecticut | Method for cloning animals with targetted genetic alterations |
EP1356031B1 (en) | 2000-03-15 | 2011-07-27 | The University Of Georgia Research Foundation, Inc. | Effective nuclear reprogramming in mammals |
IL151758A0 (en) | 2000-03-24 | 2003-04-10 | Univ Massachusetts | Prion-free transgenic ungulates |
GB0022981D0 (en) * | 2000-09-19 | 2000-11-01 | St Georges Entpr Ltd | Manipulation of spermatozoa |
WO2002026959A2 (en) | 2000-09-28 | 2002-04-04 | Sangamo Biosciences, Inc. | Nuclear reprogramming using iwsi and related chromatin remodeling atpases |
US7491534B2 (en) | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
EP1356035B1 (en) | 2000-12-22 | 2011-03-16 | Kyowa Hakko Kirin Co., Ltd. | Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells |
US20020142397A1 (en) | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
JP2002262716A (en) | 2001-03-07 | 2002-09-17 | National Agricultural Research Organization | Method for creating livestock individual using established cell line |
US20020174449A1 (en) | 2001-03-23 | 2002-11-21 | Michael West | Method for generating cloned animals using chromosome shuffling |
US20030027330A1 (en) | 2001-04-02 | 2003-02-06 | Robert Lanza | Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells |
US20060083722A1 (en) | 2001-07-18 | 2006-04-20 | Advanced Cell Technology, Inc | Methods and compositions for cell therapy |
US20040139489A1 (en) | 2001-10-05 | 2004-07-15 | Robert Lanza | Method for generating cloned animals using chromosome shuffling |
CA2473909A1 (en) | 2002-01-15 | 2003-07-24 | Advanced Cell Technology, Inc. | Cloning b and t lymphocytes |
AU2003233679A1 (en) | 2002-05-23 | 2003-12-12 | Advanced Cell Technology, Inc. | Generation of histocompatible tissues using nuclear transplantation |
US20040162917A1 (en) | 2003-02-19 | 2004-08-19 | Riso Kagaku Corporation | File download system, program for downloading file and file creating system |
AU2004232917A1 (en) | 2003-04-21 | 2004-11-04 | University Of Massachusetts | Reprogramming nuclear function with somatic cell cytoplasm |
-
2001
- 2001-12-10 US US10/015,824 patent/US20020142397A1/en not_active Abandoned
- 2001-12-11 EP EP01993249A patent/EP1356277B1/en not_active Expired - Lifetime
- 2001-12-11 AU AU2002245101A patent/AU2002245101B2/en not_active Ceased
- 2001-12-11 CA CA2429954A patent/CA2429954C/en not_active Expired - Fee Related
- 2001-12-11 JP JP2002558469A patent/JP4332348B2/en not_active Expired - Fee Related
- 2001-12-11 WO PCT/US2001/047882 patent/WO2002057415A2/en active IP Right Grant
- 2001-12-11 AT AT01993249T patent/ATE555380T1/en active
-
2004
- 2004-08-02 US US10/910,156 patent/US7736895B2/en not_active Expired - Fee Related
-
2008
- 2008-12-12 JP JP2008316566A patent/JP4304229B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001654A (en) * | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
Also Published As
Publication number | Publication date |
---|---|
EP1356277A4 (en) | 2005-09-28 |
JP2009142278A (en) | 2009-07-02 |
US20020142397A1 (en) | 2002-10-03 |
JP4332348B2 (en) | 2009-09-16 |
CA2429954A1 (en) | 2002-07-25 |
CA2429954C (en) | 2012-08-14 |
ATE555380T1 (en) | 2012-05-15 |
US7736895B2 (en) | 2010-06-15 |
JP2004524832A (en) | 2004-08-19 |
AU2002245101B2 (en) | 2007-07-05 |
US20050014258A1 (en) | 2005-01-20 |
EP1356277A2 (en) | 2003-10-29 |
EP1356277B1 (en) | 2012-04-25 |
JP4304229B2 (en) | 2009-07-29 |
WO2002057415A2 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002057415A3 (en) | Method for altering cell fate | |
WO2001089420A3 (en) | Methods and apparatus for manufacturing an intravascular stent | |
WO2005058537A3 (en) | Medical devices and methods of making the same | |
PL365887A1 (en) | Thin, high capacity absorbent structure and method for producing same | |
EP1593337A4 (en) | Overtube, producing method and placing method of the same, and method of treating intra-abdominal cavity | |
AU2002238953A1 (en) | Solar cell and its manufacturing method | |
IL207025A (en) | Post-partum mammalian placental stem cells and uses thereof for treating disorders | |
AU2001257300A1 (en) | Method for the transformation of plant cell plastids | |
HK1063528A1 (en) | Proton conducting membrane, method for producing the same, and fuel cell using the same | |
AU6459801A (en) | Compositions and methods for cell dedifferentiation and tissue regeneration | |
AU2003250666A1 (en) | Stem cells for treating pancreatic damage | |
WO2003020226A3 (en) | Cosmetic compositions comprising nanoparticles and processes for using the same | |
WO2004000006A3 (en) | Method of transforming soybean | |
DE60008959D1 (en) | Multifunctional lance for a vacuum chamber for degassing and use methods | |
EP1759582A4 (en) | Preservative solution for cells, tissues and organs comprising rare sugar and presercation method with the use of the same | |
AU2003241764A1 (en) | Fuel reformer and method of manufacturing the fuel reformer, electrode for electrochemical device, and electrochemical device | |
AU2003256483A8 (en) | Methods of electrochemically treating semiconductor substrates, and methods of forming capacitor constructions | |
MXPA03004017A (en) | Method for the treatment of inflammation. | |
AU2001236755A1 (en) | Structures and methods for improved capacitor cells | |
AU2003249263A8 (en) | Electrode for an electrochemical cell and process for making the electrode | |
WO2003078597A3 (en) | Tissue engineering | |
WO2004094611A3 (en) | Reprogramming nuclear function with somatic cell cytoplasm | |
AU2002324441A1 (en) | Composition and method for treating cells and plants | |
WO2004029226A3 (en) | Methods for altering cell fate to generate t-cells specific for an antigen of interest | |
AU2000241948A1 (en) | Method for treating cells resistant to antineoplastic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002245101 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2429954 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002558469 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001993249 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001993249 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002245101 Country of ref document: AU |